Unknotting the roles of Bcl-2 and Bcl-xL in cell death

Biochemical and Biophysical Research Communications

Volumn 333, Issue 2, 2005, Pages 336-343

  Kim, Ryungsa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Antiapoptotic protein; Bcl 2; Bcl xL; Cell death

Indexed keywords

PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CELL CYCLE G1 PHASE; CELL DEATH; CELL MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SENESCENCE;

EID: 20544437817     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.161     Document Type: Short Survey

References (65)

1. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629
2. X. Liu, C.N. Kim, J. Yang, R. Jemmerson, and X. Wang Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c Cell 86 1996 147 157
3. C. Du, M. Fang, Y. Li, L. Li, and X. Wang Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
4. R. Hegde, S.M. Srinivasula, Z. Zhang, R. Wassell, R. Mukattash, L. Cilenti, G. DuBois, Y. Lazebnik, A.S. Zervos, T. Fernandes-Alnemri, and E.S. Alnemri Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction J. Biol. Chem. 277 2002 432 438
5. S.A. Susin, H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, N. Larochette, D.R. Goodlett, R. Aebersold, D.P. Siderovski, J.M. Penninger, and G. Kroemer Molecular characterization of mitochondrial apoptosis-inducing factor Nature 397 1999 441 446
6. L.Y. Li, X. Luo, and X. Wang Endonuclease G is an apoptotic DNase when released from mitochondria Nature 412 2001 95 99
7. R. Kim Recent advances in understanding the cell death pathways activated by anticancer therapy Cancer 103 2005 1551 1560
8. J. Henry-Mowatt, C. Dive, J.C. Martinou, and D. James Role of mitochondrial membrane permeabilization in apoptosis and cancer Oncogene 23 2004 2850 2860
9. R. Khosravi-Far, and M.D. Esposti Death receptor signals to mitochondria Cancer Biol. Ther. 3 2004 1051 1057
10. K.M. Debatin Apoptosis pathways in cancer and cancer therapy Cancer Immunol. Immunother. 53 2004 153 159
11. V.C. Broaddus, T.B. Dansen, K.S. Abayasiriwardana, S.M. Wilson, A.J. Finch, L.B. Swigart, A.E. Hunt, and G.I. Evan Bid mediates apoptotic synergy between TNF-related apoptosis-inducing ligand (TRAIL) and DNA damage J. Biol. Chem. 280 2005 12486 12493
12. M. Heinrich, J. Neumeyer, M. Jakob, C. Hallas, V. Tchikov, S. Winoto-Morbach, M. Wickel, W. Schneider-Brachert, A. Trauzold, A. Hethke, and S. Schutze Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation Cell Death Differ. 11 2004 550 563
13. N.J. Waterhouse, K.A. Sedelies, K.A. Browne, M.E. Wowk, A. Newbold, V.R. Sutton, C.J. Clarke, J. Oliaro, R.K. Lindemann, P.I. Bird, R.W. Johnstone, and J.A. Trapani A central role for Bid in granzyme B-induced apoptosis J. Biol. Chem. 280 2005 4476 4482
14. L. Zhang, and B. Fang Mechanisms of resistance to TRAIL-induced apoptosis in cancer Cancer Gene Ther. 12 2005 228 237
15. H. Tominaga, S. Kodama, N. Matsuda, K. Suzuki, and M. Watanabe Involvement of reactive oxygen species (ROS) in the induction of genetic instability by radiation J. Radiat. Res. (Tokyo) 45 2004 181 188
16. H.L. Huang, L.W. Fang, S.P. Lu, C.K. Chou, T.Y. Luh, and M.Z. Lai DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation Oncogene 22 2003 8168 8177
17. K.G. Lyamzaev, D.S. Izyumov, A.V. Avetisyan, F. Yang, O.Y. Pletjushkina, and B.V. Chernyak Inhibition of mitochondrial bioenergetics: the effects on structure of mitochondria in the cell and on apoptosis Acta Biochim. Pol. 51 2004 553 562
18. T. Kanzawa, I.M. Germano, T. Komata, H. Ito, Y. Kondo, and S. Kondo Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells Cell Death Differ. 11 2004 448 457
19. I.K. Kim, Y.K. Jung, D.Y. Noh, Y.S. Song, C.H. Choi, B.H. Oh, E.S. Masuda, and Y.K. Jung Functional screening of genes suppressing TRAIL-induced apoptosis: distinct inhibitory activities of Bcl-XL and Bcl-2 Br. J. Cancer 88 2003 910 917
20. Q.M. Chen, J. Liu, and J.B. Merrett Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts Biochem. J. 347 2000 543 551
21. C.A. Schmitt Senescence, apoptosis and therapy-cutting the lifelines of cancer Nat. Rev. Cancer 3 2003 286 295
22. E.L. Arriola, A.M. Rodriguez-Lopez, J.A. Hickman, and C.M. Chresta Bcl-2 overexpression results in reciprocal downregulation of Bcl-X(L) and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis Oncogene 18 1999 1457 1464
23. S. Shimizu, T. Kanaseki, N. Mizushima, T. Mizuta, S. Arakawa-Kobayashi, C.B. Thompson, and Y. Tsujimoto Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes Nat. Cell Biol. 6 2004 1221 1228
24. F. De Giorgi, L. Lartigue, M.K. Bauer, A. Schubert, S. Grimm, G.T. Hanson, S.J. Remington, R.J. Youle, and F. Ichas The permeability transition pore signals apoptosis by directing Bax translocation and multimerization FASEB J. 16 2002 607 609
25. B. Baliga, and S. Kumar Apaf-1/cytochrome c apoptosome: an essential initiator of caspase activation or just a sideshow? Cell Death Differ. 10 2003 16 18
26. B.C. Barnhart, E.C. Alappat, and M.E. Peter The CD95 type I/type II model Semin. Immunol. 15 2003 185 193
27. M. Muzio, A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, M. Mann, P.H. Krammer, M.E. Peter, and V.M. Dixit FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 1996 817 827
28. Y. Deng, X. Ren, L. Yang, Y. Lin, and X. Wu A JNK-dependent pathway is required for TNFalpha-induced apoptosis Cell 115 2003 61 70
29. P.F. Cartron, P. Juin, L. Oliver, S. Martin, K. Meflah, and F.M. Vallette Nonredundant role of Bax and Bak in Bid-mediated apoptosis Mol. Cell. Biol. 23 2003 4701 4712
30. J. Li, Q. Li, C. Xie, H. Zhou, Y. Wang, N. Zhang, H. Shao, S.C. Chan, X. Peng, S.C. Lin, and J. Han Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death J. Cell Sci. 117 2004 4673 4680
31. K.U. Chow, S. Boehrer, S. Napieralski, D. Nowak, A. Knau, D. Hoelzer, P.S. Mitrou, and E. Weidmann In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential Leuk. Lymphoma 44 2003 165 173
32. E. Pozo-Guisado, J.M. Merino, S. Mulero-Navarro, M.J. Lorenzo-Benayas, F. Centeno, A. Alvarez-Barrientos, and P.M. Salguero Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB Int. J. Cancer 115 2005 74 84
33. X. Sheng-Tanner, E.A. Bump, and D.W. Hedley An oxidative stress-mediated death pathway in irradiated human leukemia cells mapped using multilaser flow cytometry Radiat. Res. 150 1998 636 647
34. N. Canu, R. Tufi, A.L. Serafino, G. Amadoro, M.T. Ciotti, and P. Calissano Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells J. Neurochem. 92 2005 1228 1242
35. E.A. Ostrakhovitch, and M.G. Cherian Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells Apoptosis 10 2005 111 121
36. M. Los, M. Mozoluk, D. Ferrari, A. Stepczynska, C. Stroh, A. Renz, Z. Herceg, Z.Q. Wang, and K. Schulze-Osthoff Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling Mol. Biol. Cell 13 2002 978 988
37. D.G. Breckenridge, and D. Xue Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases Curr. Opin. Cell Biol. 16 2004 647 652
38. X. Wang, J. Zhang, H.P. Kim, Y. Wang, A.M. Choi, and S.W. Ryter Bcl-XL disrupts death-inducing signal complex formation in plasma membrane induced by hypoxia/reoxygenation FASEB J. 18 2004 1826 1833
39. S.A. Keogh, H. Walczak, L. Bouchier-Hayes, and S.J. Martin Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis FEBS Lett. 471 2000 93 98
40. U. Naumann, J. Wischhusen, S. Weit, J. Rieger, H. Wolburg, U. Massing, and M. Weller Alkylphosphocholine-induced glioma cell death is BCL-X(L)-sensitive, caspase-independent and characterized by massive cytoplasmic vacuole formation Cell Death Differ. 11 2004 1326 1341
41. R.K. Srivastava, Q.S. Mi, J.M. Hardwick, and D.L. Longo Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis Proc. Natl. Acad. Sci. USA 96 1999 3775 3780
42. E.J. Uhlmann, T. Subramanian, C.A. Vater, R. Lutz, and G. Chinnadurai A potent cell death activity associated with transient high level expression of BCL-2 J. Biol. Chem. 273 1998 17926 17932
43. M.D. Berardo, R.M. Elledge, C. de Moor, G.M. Clark, C.K. Osborne, and D.C. Allred bcl-2 and apoptosis in lymph node positive breast carcinoma Cancer 82 1998 1296 1302
44. P. Athanassiadou, T. Dosios, E. Petrakakou, A. Liossi, C. Zerva, and P. Athanassiades p53 and bcl-2 protein expression in non-small-cell lung carcinoma Diagn. Cytopathol. 19 1998 255 259
45. Y. Tsujimoto, L.R. Finger, J. Yunis, P.C. Nowell, and C.M. Croce Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation Science 226 1984 1097 1099
46. Y. Wu, J.W. Mehew, C.A. Heckman, M. Arcinas, and L.M. Boxer Negative regulation of bcl-2 expression by p53 in hematopoietic cells Oncogene 20 2001 240 251
47. A.Y. Nikolaev, M. Li, N. Puskas, J. Qin, and W. Gu Parc: a cytoplasmic anchor for p53 Cell 112 2003 29 40
48. P.J. Beale, P. Rogers, F. Boxall, S.Y. Sharp, and L.R. Kelland BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma Br. J. Cancer 82 2000 436 440
49. Y. Liang, C. Yan, K.D. Nylander, and N.F. Schor Early events in Bcl-2-enhanced apoptosis Apoptosis 8 2003 609 616
50. Y. Liang, K.D. Nylander, C. Yan, and N.F. Schor Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2 Mol. Pharmacol. 61 2002 142 149
51. N.F. Schor, Y.Y. Tyurina, J.P. Fabisiak, V.A. Tyurin, J.S. Lazo, and V.E. Kagan Selective oxidation and externalization of membrane phosphatidylserine: Bcl-2-induced potentiation of the final common pathway for apoptosis Brain Res. 831 1999 125 130
52. J.H. Jang, and Y.J. Surh Possible role of NF-kappaB in Bcl-X(L) protection against hydrogen peroxide-induced PC12 cell death Redox Rep. 9 2004 343 348
53. N.F. Schor, C.M. Rudin, A.R. Hartman, C.B. Thompson, Y.Y. Tyurina, and V.E. Kagan Cell line dependence of Bcl-2-induced alteration of glutathione handling Oncogene 19 2000 472 476
54. E. Crescenzi, G. Palumbo, and H.J. Brady Bcl-2 activates a programme of premature senescence in human carcinoma cells Biochem. J. 375 2003 263 274
55. M. Sasaki, T. Kumazaki, H. Takano, M. Nishiyama, and Y. Mitsui Senescent cells are resistant to death despite low Bcl-2 level Mech. Ageing Dev. 122 2001 1695 1706
56. V.L. Johnson, I.R. Cooper, J.R. Jenkins, and S.C. Chow Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells Exp. Cell Res. 251 1999 175 184
57. I.B. Roninson Tumor cell senescence in cancer treatment Cancer Res. 63 2003 2705 2715
58. C.A. Schmitt, J.S. Fridman, M. Yang, S. Lee, E. Baranov, R.M. Hoffman, and S.W. Lowe A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy Cell 109 2002 335 346
59. P. Marini, V. Jendrossek, E. Durand, C. Gruber, W. Budach, and C. Belka Molecular requirements for the combined effects of TRAIL and ionising radiation Radiother. Oncol. 68 2003 189 198
60. J. Umeda, S. Sano, K. Kogawa, N. Motoyama, K. Yoshikawa, S. Itami, G. Kondoh, T. Watanabe, and J. Takeda In vivo cooperation between Bcl-xL and the phosphoinositide 3-kinase-Akt signaling pathway for the protection of epidermal keratinocytes from apoptosis FASEB J. 17 2003 610 620
61. Y. Shao, Z. Gao, P.A. Marks, and X. Jiang Apoptotic and autophagic cell death induced by histone deacetylase inhibitors Proc. Natl. Acad. Sci. USA 101 2004 18030 18035
62. P.A. Marks, and X. Jiang Histone deacetylase inhibitors in programmed cell death and cancer therapy Cell Cycle 4 2005
63. +-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis Cell Death Differ. 11 2004 760 770
64. K.M. Anderson, W. Alrefai, P. Bonomi, T.M. Seed, P. Dudeja, Y. Hu, and J.E. Harris Caspase-dependent and -independent panc-1 cell death due to actinomycin D and MK 886 are additive but increase clonogenic survival Exp. Biol. Med. (Maywood) 228 2003 915 925
65. P. Nicotera, and G. Melino Regulation of the apoptosis-necrosis switch Oncogene 23 2004 2757 2765